Gene therapy products present a unique set of challenges for the control of host cell protein impurities.
Art Cansizoglu
Advertisement
Art Cansizoglu, PhD, is senior scientist with Charles River.
Articles by Art Cansizoglu
Advertisement
Latest Updated Articles
Detecting Residual HCPs Demands a Holistic ApproachPublished: July 15th 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
5
